Journal of Immune Based Therapies and Vaccines
Publisher: BioMed Central
Journal of Immune Based Therapies and Vaccines is an Open Access,
peer-reviewed, online journal dedicated to all aspects of therapeutic
applications of immunology.
Journal of Immune Based Therapies and Vaccines aims to advance the
understanding of specific immunological mechanisms involved in
protection for efficacious vaccines and the immune correlates of the
therapeutic action of Immune Based Therapies (IBTs). The areas of
vaccines and IBTs encompass many different disciplines as immune based
therapies and vaccines are now being developed for infectious diseases,
transplantation, cancer, allergic diseases, and autoimmune diseases.
Due to rapid developments, there is a need for a journal that is focused
solely on immune based therapies and vaccines. The goal of this journal
is to provide an objective peer review process conducted by those
knowledgeable in the field. The clear advantage of this journal is the
rapid dissemination of high-quality, Open Access scientific work, which
should provoke additional scientific hypothesis, thereby advancing the
The Journal of Immune Based Therapies and Vaccines considers the
following types of articles:
* Original research - reports of data from original research
related to IBTs and vaccines or related to immune pathogenesis of
diseases targeted by IBTs and vaccines
* Reviews - summaries of recent insights in specific research areas
within the scope of Journal of Immune Based Therapies and Vaccines. They
can be submitted either upon specific invitation or editorial acceptance
of an author's proposal. To submit a proposal, authors should send a
tentative title and abstract to the Editorial Office and justify their
expertise in the target area, and also both the scientific relevance and
the lack of recent reviews on the topic.
To facilitate rapid publication and to minimize administrative costs,
Journal of Immune Based Therapies and Vaccines accepts only online
submission. The submission process is compatible with version 3.0 or
later of Internet Explorer and Netscape Navigator, and with most other
modern web browsers. It can be used from PC, Mac, or Unix platforms.
Abstracts available online. Full text available in PDF format.
Current Issue: 2004, 2:4 (13 February 2004)
Date: 6 April 2004